Evidence map›Paper›PMID 19839005›Full record

ArticleHepatology (Baltimore, Md.)2009

The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production.

Oscar Gonzalez, Vanessa Fontanes, Santanu Raychaudhuri, Rachel Loo, Joseph Loo, Vaithilingaraja Arumugaswami, Ren Sun, Asim Dasgupta, Samuel W French

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01438320 (A Phase 1 Study of Quercetin in Patients With Hepatitis C), which is not on this map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01438320 phase1completednot on this mapstarted 2011, after this paper: background citation

A Phase 1 Study of Quercetin in Patients With Hepatitis C

TypeinterventionalSponsorUniversity of California, Los AngelesRan2011 to 2014Enrolled34ConditionsChronic Hepatitis CArmsQuercetin
3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 191 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Heat shock proteins and viral infection.Frontiers in immunology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19.Environmental science and pollution research international · 2021
    Review
  18. Review
  19. Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection.International journal of molecular sciences · 2021
    Review
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Oscar GonzalezDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA 90095-1732, USA.
Vanessa Fontanes
Santanu Raychaudhuri
Rachel Loo
Joseph Loo
Vaithilingaraja Arumugaswami
Ren Sun
Asim Dasgupta
Samuel W French
University of California, Los Angeles · USGTx (United States) · USUCLA Jonsson Comprehensive Cancer Center

Funding

Heat Shock Protein Synthesis Inhibitor Treatment of Hepatitis C Viral InfectionR01DK090794 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FRENCH, SAMUEL WHEELER · 2011 to 2015
$1.7M
Interaction of TCL1 with a novel exoribonucleaseK22CA120147 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FRENCH, SAMUEL WHEELER · 2007 to 2009
$458k
Towards Developing type 1a HCV cell culture modelR21AI072180 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DASGUPTA, ASIM · 2007 to 2008
$420k
NCI NIH HHS 1K22CA120147-01A1NCI NIH HHS K22 CA120147NIAID NIH HHS AI 072180NIAID NIH HHS R21 AI072180NIDDK NIH HHS R01 DK090794
6 · The paper itself

Abstract

unlabelledThe hepatitis C viral (HCV) genome is translated through an internal ribosome entry site (IRES) as a single polyprotein precursor that is subsequently cleaved into individual mature viral proteins. Nonstructural protein 5A (NS5A) is one of these proteins that has been implicated in regulation of viral genome replication, translation from the viral IRES and viral packaging. We sought to identify cellular proteins that interact with NS5A and determine whether these interactions may play a role in viral production. Mass spectrometric analysis of coimmunoprecipitated NS5A complexes from cell extracts identified heat shock proteins (HSPs) 40 and 70. We confirmed an NS5A/HSP interaction by confocal microscopy demonstrating colocalization of NS5A with HSP40 and with HSP70. Western analysis of coimmunoprecipitated NS5A complexes further confirmed interaction of HSP40 and HSP70 with NS5A. A transient transfection, luciferase-based, tissue culture IRES assay demonstrated NS5A augmentation of HCV IRES-mediated translation, and small interfering RNA (siRNA)-mediated knockdown of HSP70 reduced this augmentation. Treatment with an inhibitor of HSP synthesis, Quercetin, markedly reduced baseline IRES activity and its augmentation by NS5A. HSP70 knockdown also modestly reduced viral protein accumulation, whereas HSP40 and HSP70 knockdown both reduced infectious viral particle production in an HCV cell culture system using the J6/JFH virus fused to the Renilla luciferase reporter. Treatment with Quercetin reduced infectious particle production at nontoxic concentrations. The marked inhibition of virus production by Quercetin may partially be related to reduction of HSP40 and HSP70 and their potential involvement in IRES translation, as well as viral morphogenesis or secretion.

conclusionQuercetin may allow for dissection of the viral life cycle and has potential therapeutic use to reduce virus production with low associated toxicity.

Indexed as

Cell LineHeat-Shock ProteinsHepacivirusHumansQuercetinRNA-Dependent RNA PolymeraseRNA, Small InterferingViral Nonstructural ProteinsVirus ReplicationHeat-Shock ProteinsNS-5 protein, hepatitis C virusQuercetinRNA-Dependent RNA PolymeraseRNA, Small InterferingViral Nonstructural Proteins

Identifiers

PMID19839005
PMCPMC3846025
OpenAlexW2004009484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.